Evidence map›Paper›PMID 27660698›Full record

ReviewWorld journal of diabetes2016

Diabetes mellitus and cognitive impairments.

Elham Saedi, Mohammad Reza Gheini, Firoozeh Faiz, Mohammad Ali Arami

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of diabetes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 1 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 1 synthesis or guideline pooled it, 263 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Cognitive Impairments and Health System Outcomes in Inpatient Rehabilitation: A Comparison of Patients With Stroke and Those With Type II Diabetes Mellitus.The American journal of occupational therapy : official publication of the American Occupational Therapy Association · 2026
    Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Elham SaediElham Saedi, Amir Alam Research Center, Department of Internal Medicine, Division of Neurology, Amir Alam Hospital, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
Mohammad Reza GheiniElham Saedi, Amir Alam Research Center, Department of Internal Medicine, Division of Neurology, Amir Alam Hospital, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
Firoozeh FaizElham Saedi, Amir Alam Research Center, Department of Internal Medicine, Division of Neurology, Amir Alam Hospital, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
Mohammad Ali AramiElham Saedi, Amir Alam Research Center, Department of Internal Medicine, Division of Neurology, Amir Alam Hospital, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
Tehran University of Medical Sciences · IRMilad Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is strong evidence that diabetes mellitus increases the risk of cognitive impairment and dementia. Insulin signaling dysregulation and small vessel disease in the base of diabetes may be important contributing factors in Alzheimer's disease and vascular dementia pathogenesis, respectively. Optimal glycemic control in type 1 diabetes and identification of diabetic risk factors and prophylactic approach in type 2 diabetes are very important in the prevention of cognitive complications. In addition, hypoglycemic attacks in children and elderly should be avoided. Anti-diabetic medications especially Insulin may have a role in the management of cognitive dysfunction and dementia but further investigation is needed to validate these findings.

Indexed as

Alzheimer’s diseaseCognitive disordersDementiaDiabetesInsulin

Identifiers

PMID27660698
PMCPMC5027005
OpenAlexW2509224801

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.